Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

OXF BD 02

Copy Product Info
😃Good
Catalog No. T23115Cas No. 1429129-68-9
Alias OXFBD02

OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.

OXF BD 02

OXF BD 02

Copy Product Info
😃Good
Purity: 98.25%
Catalog No. T23115Alias OXFBD02Cas No. 1429129-68-9
OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$100In StockIn Stock
5 mg$247In StockIn Stock
10 mg$372In StockIn Stock
25 mg$689In StockIn Stock
50 mg$986In StockIn Stock
100 mg$1,320In StockIn Stock
500 mg$2,660-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.25%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

OXF BD 02 AI Summary
OXF BD 02 exhibits cytotoxicity against various human cell lines with high IC50 values (>10000.0 nM) for HeLa and U2OS cells at 24 hours, and for NCI-H1975 and A549 cells at 72 hours. However, it has a much lower IC50 value of 794.0 nM for MV4-11 cells at 72 hours, indicating a more potent effect on this cell line. The compound shows growth inhibition of cancer cell lines such as A498, MCF7, HT-29, and HL-60(TB) with GI50 values between 1250.0 nM and 4540.0 nM. It inhibits the BRD4 bromodomain 1 with an IC50 of 384.0 nM. In terms of metabolic stability, OXF BD 02 has a short half-life (T1/2 = 0.6633 hr) in human liver microsomes and moderate intrinsic clearance (CL = 34.8 mL.min-1.g-1). Additionally, it shows activity against various bromodomain proteins in BROMOscan assays and demonstrates TGI (Total Growth Inhibition) at higher concentrations. The compound also inhibits human HDAC6 enzyme activity with a -20.51% inhibition using a commercial peptide substrate and a 2.55% inhibition using a custom peptide substrate..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.
Targets&IC50
BRD4:382 nM
SynonymsOXFBD02
Chemical Properties
Molecular Weight295.33
FormulaC18H17NO3
Cas No.1429129-68-9
SmilesCC=1C(C2=CC(C(O)C3=CC=CC=C3)=CC(O)=C2)=C(C)ON1
Relative Density.1.233 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy OXF BD 02 | purchase OXF BD 02 | OXF BD 02 cost | order OXF BD 02 | OXF BD 02 chemical structure | OXF BD 02 formula | OXF BD 02 molecular weight